Evidence map›Paper›PMID 30002733›Full record

ArticleGut pathogens2018

Gut colonization with vancomycin-resistant

Jordan E Axelrad, Benjamin Lebwohl, Edward Cuaresma, Ken Cadwell, Peter H R Green, Daniel E Freedberg

Abstract read
In one paragraph

Article in Gut pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Medicina (Kaunas, Lithuania) · 2025
    Observational
  4. Article
  5. Article
  6. Review
  7. Journal of clinical medicine · 2023
    Review
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jordan E Axelrad1Division of Gastroenterology, Department of Medicine, Inflammatory Bowel Disease Center, NYU Langone Health, 240 East 38th Street, 23rd Floor, New York, NY USA.
Benjamin Lebwohl2Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, NY USA.
Edward Cuaresma2Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, NY USA.
Ken Cadwell3Kimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine, New York, NY USA.
Peter H R Green2Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, NY USA.
Daniel E Freedberg2Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, NY USA.

Funding

Loss of Gastrointestinal Colonization Resistance and Antibiotic-Resistant Infections in the Intensive Care UnitK23DK111847 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FREEDBERG, DANIEL E. · 2017 to 2020
$608k
NIDDK NIH HHS K23 DK111847
6 · The paper itself

Abstract

backgroundGut colonization with vancomycin-resistant

methodsWe performed a retrospective cohort study of adults admitted to an ICU from 2012 to 2017 who were screened for VRE colonization and subsequently underwent stool testing with a gastrointestinal pathogen PCR panel (GI PCR) with or without PCR testing for

resultsOf 761 patients who underwent VRE screening and subsequent GI PCR, 131 (17%) were colonized with VRE. Patients with VRE colonization were less likely to test positive on GI PCR compared to patients without VRE (9.2% vs 18%, p = 0.01); specifically for

conclusionsVRE colonization was associated with a decreased risk of subsequent non-

Indexed as

Clostridium difficileEnteric infectionMultiplex PCR testingVancomycin-resistant enterococci (VRE)

Identifiers

PMID30002733
PMCPMC6038175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.